Home > Drug List > Baricitinib > News of Baricitinib

News of Baricitinib

This medicinal product first obtained marketing authorization in the European Union (EU) in February 2017, and completed its latest renewal in November 2021.

Baricitinib

Baricitinib

Indications： It is indicated for the treatment of various immune-related diseases in adults and children aged 2 years and older, including rheumatoid arthritis, atopic dermatitis, alopecia areata, and juvenile idi

Scan code
Whatsapp

Medicine-related columns

Recommended Articles

Related Articles

There is no data under this category！
Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More

Hospital Departments
Latest Articles
Medicine Updates

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.

Product

Product

Contact US

Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos

E-mail:laoslucius@gmail.com

Whatsapp:

ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved

whatsapp